Genmab A/S (GMAB)
28.14
-0.26
(-0.92%)
USD |
NASDAQ |
Apr 09, 10:21
Genmab Market Cap : 17.33B for April 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 163.66B |
| AbbVie, Inc. | 372.80B |
| Ascendis Pharma A/S | 14.74B |
| Zealand Pharma A/S | 3.140B |
| Bavarian Nordic A/S | 2.383B |
Market Cap Related Metrics
| PE Ratio | 18.67 |
| PS Ratio | 4.939 |
| Price to Book Value | 3.045 |
| Price to Free Cash Flow | 16.23 |
| Price | 28.14 |
| Earnings Yield | 5.36% |
| Operating PE Ratio | 14.70 |
| Normalized PE Ratio | 16.61 |